Procalcitonin (PCT) Assay Market Skyrockets to US$ 512.9 Million by 2033-FMI Study

The global procalcitonin (PCT) assay market is on a trajectory of substantial growth, with a projected market size of US$ 280.6 million in 2023 and an anticipated CAGR of 6.2% during the forecast period, propelling it to a valuation of US$ 512.9 million by 2033.

One of the key drivers for this growth is the increasing incidence of lung cancer, emphasizing the need for accurate and early diagnosis. The PCT assay market has experienced remarkable expansion owing to heightened awareness about the critical role of early and precise diagnosis in bacterial infections.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17617

The Procalcitonin (PCT) assay market focuses on diagnostic tests that measure procalcitonin levels in the bloodstream. Procalcitonin is a precursor protein to the hormone calcitonin, and its production is triggered by bacterial infections. The market is committed to improving patient care by offering advanced diagnostic solutions for bacterial infections.

As the Procalcitonin (PCT) Assay Market continues to advance, it is anticipated to play a pivotal role in enhancing the early detection and management of bacterial infections, contributing to better healthcare outcomes.

Key Takeaways:

1. Market Growth: The market is expected to experience substantial growth, with a projected valuation of $512.9 million by 2033, driven by a CAGR of 6.2% during the forecast period.
2. Lung Cancer Incidences: The increasing incidence of lung cancer is a significant driver for market growth, underlining the need for early and accurate diagnosis of bacterial infections.
3. Awareness and Importance: Growing awareness about the importance of early and precise diagnosis of bacterial infections has contributed to the market’s expansion.
4. PCT Assay Definition: The market revolves around diagnostic tests that measure procalcitonin levels in the bloodstream. Procalcitonin is a precursor protein produced in response to bacterial infections.
5. Enhanced Diagnostic Solutions: The PCT assay market is committed to offering advanced diagnostic solutions for bacterial infections, with the goal of improving patient care.
6. Early Detection: PCT assays play a pivotal role in the early detection of bacterial infections, allowing for prompt treatment and better healthcare outcomes.
7. Clinical Utility: Procalcitonin assays are valuable tools for clinicians to assess the presence and severity of bacterial infections, guiding treatment decisions.
8. Patient Care: The focus on precise diagnosis and early intervention is aligned with providing optimal patient care and improving healthcare outcomes.
9. Innovative Diagnostics: The market’s growth reflects ongoing innovations in diagnostic technologies and their impact on the field of bacterial infection detection.
10. Global Impact: The Procalcitonin (PCT) Assay Market contributes to the global efforts to enhance healthcare by improving the accuracy and timeliness of bacterial infection diagnosis.

Key Players in the Procalcitonin (PCT) Assay Market:

• J. Mitra & Co. Pvt. Ltd.
• Thermo Fisher Scientific Inc.
• Elabscience Biotechnology Inc.
• CUSABIO TECHNOLOGY LLC
• Wuhan Fine Biotech Co., Ltd.
• Company ABclonal, Inc.
• Nanjing Vazyme Biotech Co.,Ltd.
• RayBiotech Life, Inc.
• Hipro Biotechnology Co.,Ltd.
• Vitrosens Biotechnology
• bioMérieux SA
• ELK Biotechnology CO.,Ltd.
• Immuno-Biological Laboratories, Inc.
• BISAF
• Roche Diagnostics

Key Developments:

• In November 2020, Roche and bioMérieux announced a collaboration to improve antibiotic stewardship by developing and providing PCT assays on Roche’s cobas platforms.
• In February 2020, bioMérieux received FDA clearance for the Vidas BRAHMS PCT assay, which is an automated immunoassay platform for measuring PCT levels.

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-17617

Procalcitonin (PCT) Assay Market Segmentation:

By Sample Type:

• Serum
• Plasma
• Cell Culture Medium
• Other Biological Fluids

By Product:

• Test Kits
  • Procalcitonin ELISA test kits
  • Procalcitonin CLIA kits
  • PCT Immunochromatography KITS
  • PCT Rapid Test Kit
• Analyzer & Instruments
• Consumables

By Purpose:

• Clinical Use
• Research Use Only

By End User:

• Hospital
• Specialty Clinics
• Academic and Research Institute
• Diagnostics Laboratories

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube